Juan Sanchez
CIK: 0002094238
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NVCT
Nuvectis Pharma, Inc.
Director
Discretionary Trading P&L
Holdings
About Sanchez Juan
Sanchez Juan (SEC CIK 0002094238) files insider reports with the SEC as Director of Nuvectis Pharma, Inc. (NVCT).
Signal8 holds 4 ownership filings by Sanchez Juan (1 Form 3, 3 Form 4), filed between Oct 31, 2025 and Jun 12, 2026. Those filings report 3 transactions, from Sep 22, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Sanchez Juan's filings is in FORT LEE, NJ.
Recent filings by Sanchez Juan
Other insiders filing for Nuvectis Pharma, Inc. (NVCT)
- Carson Michael J., Vice President, Finance
- Mosseri Marlio Charles, 10% Owner
- BENTSUR RON, Chairman & CEO
- Hoberman Kenneth, Director
- Oliviero James F III, Director
- Kaplan Matthew L., Director